Inhibition of cell-mediated immunity in type 1 diabetes by beta cell-targeted PD-1 agonists in pancreas tissue slices.

Saved in:
Bibliographic Details
Title: Inhibition of cell-mediated immunity in type 1 diabetes by beta cell-targeted PD-1 agonists in pancreas tissue slices.
Authors: Becker MW; J. Crayton Pruitt Family Department of Biomedical Engineering, Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL, USA., Brown M; Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.; University of Florida Diabetes Institute, University of Florida, Gainesville, FL, USA., Wiseman K; Immunocore Ltd., Abingdon, United Kingdom., Chiodetti AL; Immunocore Ltd., Abingdon, United Kingdom., Huber MK; J. Crayton Pruitt Family Department of Biomedical Engineering, Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL, USA.; Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.; University of Florida Diabetes Institute, University of Florida, Gainesville, FL, USA., Cuaycal AE; J. Crayton Pruitt Family Department of Biomedical Engineering, Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL, USA.; University of Florida Diabetes Institute, University of Florida, Gainesville, FL, USA.; Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA., Sintara P; J. Crayton Pruitt Family Department of Biomedical Engineering, Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL, USA., Ferreira SM; J. Crayton Pruitt Family Department of Biomedical Engineering, Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL, USA., Smurlick D; J. Crayton Pruitt Family Department of Biomedical Engineering, Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL, USA., Barra JM; University of Florida Diabetes Institute, University of Florida, Gainesville, FL, USA.; Department of Pharmacology & Therapeutics, College of Medicine, University of Florida, Gainesville, FL, USA., Ladd AM; University of Florida Diabetes Institute, University of Florida, Gainesville, FL, USA.; Department of Pharmacology & Therapeutics, College of Medicine, University of Florida, Gainesville, FL, USA., Drotar DM; Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.; University of Florida Diabetes Institute, University of Florida, Gainesville, FL, USA., Atkinson MA; Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.; University of Florida Diabetes Institute, University of Florida, Gainesville, FL, USA.; Department of Pediatrics, College of Medicine, University of Florida, Gainesville, FL, USA., Weber P; Immunocore Ltd., Abingdon, United Kingdom., Al-Mossawi H; Immunocore Ltd., Abingdon, United Kingdom., Russ HA; University of Florida Diabetes Institute, University of Florida, Gainesville, FL, USA.; Department of Pharmacology & Therapeutics, College of Medicine, University of Florida, Gainesville, FL, USA., Mahon TM; Immunocore Ltd., Abingdon, United Kingdom., Brusko TM; Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.; University of Florida Diabetes Institute, University of Florida, Gainesville, FL, USA.; Department of Pediatrics, College of Medicine, University of Florida, Gainesville, FL, USA.; Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL, USA., Bossi G; Immunocore Ltd., Abingdon, United Kingdom., Phelps EA; J. Crayton Pruitt Family Department of Biomedical Engineering, Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL, USA.; Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.; University of Florida Diabetes Institute, University of Florida, Gainesville, FL, USA.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 Oct 22. Date of Electronic Publication: 2025 Oct 22.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.1101/2025.10.21.683528